A detailed history of Mackenzie Financial Corp transactions in Vericel Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 3,924 shares of VCEL stock, worth $191,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,924
Holding current value
$191,687
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 20, 2025

BUY
$40.05 - $59.11 $157,156 - $231,947
3,924 New
3,924 $215,000
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $127,608 - $205,342
3,924 New
3,924 $204,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.3B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.